单位:[1]Department of Biliary-Pancreatic Surgery Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China外科学系胆胰外科华中科技大学同济医学院附属同济医院[2]Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China华中科技大学同济医学院附属同济医院[3]Institute of Integrated Traditional Chinese and Western Medicine Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China中西医结合研究所华中科技大学同济医学院附属同济医院[4]Department of Plastic and Cosmetic Surgery Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China外科学系整形美容外科华中科技大学同济医学院附属同济医院
Ferroptosis, an iron-dependent form of regulated cell death driven by excessive accumulation of lipid peroxides, has become a promising strategy in cancer treatment. Cancer cells exploit antioxidant proteins, including Ferroptosis Suppressor Protein 1 (FSP1), to prevent ferroptosis. In this study, it is found that the E3 ubiquitin ligase TRIM21 bound to FSP1 and mediated its ubiquitination on K322 and K366 residues via K63 linkage, which is essential for its membrane translocation and ferroptosis suppression ability. It is further verified the protective role of the TRIM21-FSP1 axis in RSL3-induced ferroptosis in cancer cells and a subcutaneous tumor model. Moreover, TRIM21 is highly expressed in multiple gastrointestinal (GI) tumors, and its expression is further stimulated upon ferroptosis induction in cancer cells and the KPC mouse model. In summary, This study identifies TRIM21 as a negative regulator of ferroptosis through K63 ubiquitination of FSP1, which can serve as a therapeutic target to enhance the chemosensitivity of tumors based on ferroptosis induction.
基金:
National Key Research and Development Program of China [2022YFA1105300-03, 2019YFC1315905]; National Natural Science Foundation of China [81900518, 82103452, 82073249]
第一作者单位:[1]Department of Biliary-Pancreatic Surgery Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China[2]Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Biliary-Pancreatic Surgery Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China[2]Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases Affiliated Tongji Hospital Tongji Medical College Huazhong University of Science and Technology 1095 Jiefang Ave,Wuhan,Hubei 430030,China
推荐引用方式(GB/T 7714):
Gong Jun,Liu Yuhui,Wang Wenjia,et al.TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers[J].ADVANCED SCIENCE.2023,10(29):doi:10.1002/advs.202302318.
APA:
Gong, Jun,Liu, Yuhui,Wang, Wenjia,He, Ruizhi,Xia, Qilong...&Qin, Renyi.(2023).TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers.ADVANCED SCIENCE,10,(29)
MLA:
Gong, Jun,et al."TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers".ADVANCED SCIENCE 10..29(2023)